country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-124069

Copy Link Print Information

M-525

M-525 is a first-in-class, highly potent, irreversible and covalent menin-MLL protein-protein interaction inhibitor. M-525 binds to menin with an IC₅₀ of 3 nM and achieves low nanomolar potencies in cell growth inhibition and in suppression of MLL regulated gene expression in MLL leukemia cells. Anti-leukemia activity.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 2173582-08-4
分子式: C₃₉H₅₁FN₆O₅S
分子量:734.92

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (266 KB)

M-525 構造式

CAS 番号: 2173582-08-4

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

Epigenetic Reader Domain アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
HL-60	GI₅₀	0.9 μM Compound: 9; M-525	Anticancer activity against human HL-60 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human HL-60 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
HL-60	IC₅₀	1500 nM Compound: M-525	Growth inhibition of human HL60 cells after 7 days by WST-8 assay Growth inhibition of human HL60 cells after 7 days by WST-8 assay	[PMID: 32338903]
K562	GI₅₀	0.9 μM Compound: 9; M-525	Anticancer activity against human K562 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human K562 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
MOLM-13	GI₅₀	15.4 nM Compound: 15; M-525	Antiproliferative activity against human MOLM-13 cells Antiproliferative activity against human MOLM-13 cells	[PMID: 34726905]
MOLM-13	GI₅₀	2.3 nM Compound: 9; M-525	Anticancer activity against human MOLM-13 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human MOLM-13 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
MOLM-13	IC₅₀	19 nM Compound: M-525	Growth inhibition of human MOLM13 cells after 7 days by WST-8 assay Growth inhibition of human MOLM13 cells after 7 days by WST-8 assay	[PMID: 32338903]
MOLM-14	GI₅₀	2.3 nM Compound: 9; M-525	Anticancer activity against human MOLM-14 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human MOLM-14 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
MOLM-16	GI₅₀	0.9 μM Compound: 9; M-525	Anticancer activity against human MOLM16 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human MOLM16 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
MONO-MAC-6	GI₅₀	2.3 nM Compound: 9; M-525	Anticancer activity against human MONO-MAC-6 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human MONO-MAC-6 cells harboring MLL-AF9 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
MV4-11	GI₅₀	2.3 nM Compound: 9; M-525	Anticancer activity against human MV4-11 cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human MV4-11 cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
MV4-11	GI₅₀	2.7 nM Compound: 15; M-525	Antiproliferative activity against human MV4-11 cells Antiproliferative activity against human MV4-11 cells	[PMID: 34726905]
MV4-11	IC₅₀	4 nM Compound: M-525	Growth inhibition of human MV4-11 cells after 7 days by WST-8 assay Growth inhibition of human MV4-11 cells after 7 days by WST-8 assay	[PMID: 32338903]
RS4-11	GI₅₀	2.3 nM Compound: 9; M-525	Anticancer activity against human RS4-11 cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human RS4-11 cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
SEM	GI₅₀	2.3 nM Compound: 9; M-525	Anticancer activity against human SEM cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human SEM cells harboring MLL-AF4 fusion protein assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]
SKM-1	GI₅₀	0.9 μM Compound: 9; M-525	Anticancer activity against human SKM-1 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay Anticancer activity against human SKM-1 cells assessed as cell growth inhibition measured after 7 days by WST-8 assay	[PMID: 36528996]

体外実験

M-525 achieves an IC₅₀ of 3 nM in the MV4;11 cell line and has an IC₅₀ of 2 µM in the HL-60 cell line. M-525 (3-300 nM; 24 h) is potent and effective in suppressing the expression of MEIS1 and HOX genes in MV4;11 cells carrying the MLL-AF4 fusion and in MOLM-13 cells carrying the MLL-AF9 fusion. It demonstrates high cellular specificity over non-MLL leukemia cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

化学情報

CAS 番号 2173582-08-4
分子量 734.92
分子式 C₃₉H₅₁FN₆O₅S
SMILES

O=C(OC)N[C@@H]1[C@@H]([C@](C2CCN(CC3CN(C4=CC=C(S(=O)(C5CN(C(/C=C/CN(C)C)=O)C5)=O)C=C4)C3)CC2)(C#N)C6=CC=CC(F)=C6)CCC1
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (266 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Xu S, et al. Design of the First-in-Class, Highly Potent Irreversible Inhibitor Targeting the Menin-MLL Protein-Protein Interaction. Angew Chem Int Ed Engl. 2018 Feb 5;57(6):1601-1605. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ

Amount: USD 0.00

生物活性
- 製品説明
- 体外実験
化学情報
純度とドキュメンテーション
参考文献

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

M-525

Epigenetic Reader Domain アイソフォーム固有の製品をすべて表示